Coronavirus (1422) Adherence of Clinical Practice Guidelines for Pharmacologic Treatments of Hospitalized Patients With COVID-19 to Trustworthy Standard: A Systematic Review (2)

25 December, 2021

Last week we noted a systematic review that concluded: 'Few COVID-19 Clinical Practice Guidelines met National Academy of Medicine standards for trustworthy guidelines. Approaches that prioritize engagement of a methodologist and multidisciplinary collaborators from at least 2 WHO regions may lead to the production of fewer, high-quality CPGs that are poised for updates as new evidence emerges.'

I suggested 'It is especially worrying that international CPGs produced in North America and Europe are not demonstrating high quality. The rest of the world often relies on such guidelines, so those producing international guidelines *must* use the highest possible standards. It is also a concern that only one-quarter of the guidelines explicitly reported their funding sources. Surely this should be mandatory, especially for international guidelines?'

I look forward to comments from those who help to produce, adapt and use international clinical guidelines, and how these can be improved. The term 'methodologist' has been used only a handful of times on HIFA. Would anyone like to say more about this role?

Best wishes, Neil

Neil Pakenham-Walsh, HIFA Coordinator,